Related Experiment Videos
ACE inhibitors vs ARBs: is one class better for heart failure
Mark E Dunlap1, Ross C Peterson
1Case Western Reserve University School of Medicine, and Louis B. Stokes Cleveland VA Medical Center, Cleveland, OH 44106, USA. med3@po.cwru.edu
Cleveland Clinic Journal of Medicine
|May 23, 2002
Abstract:
Although angiotensin-converting enzyme (ACE) inhibitors decrease mortality in heart failure, they incompletely suppress angiotensin II with long-term therapy. Since angiotensin receptor blockers (ARBs) block the biologic effects of angiotensin II more completely than ACE inhibitors, they could be beneficial in the treatment of heart failure.